,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,4.51782402683188e-05,0.0357649315961702
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,8.70192982875187e-05,0.0357649315961702
3,WP_IRON_METABOLISM_DISORDERS,10,Up,0.00114192161235771,0.312886521786013
4,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.00185687006225889,0.381586797794201
5,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00253941473265402,0.417479782048322
6,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00451435484999481,0.514033562052572
7,WP_ONECARBON_METABOLISM,22,Up,0.0050144699545279,0.514033562052572
8,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.00571024880707013,0.514033562052572
9,WP_IDO_METABOLIC_PATHWAY,7,Down,0.0062320024639227,0.514033562052572
10,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.00661490945550622,0.514033562052572
11,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Up,0.00687879462600766,0.514033562052572
12,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0075843895415985,0.517290633666898
13,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.00840734729553697,0.517290633666898
14,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.00881030276318317,0.517290633666898
15,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.0106360062708185,0.582853143640852
16,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.0134834998452791,0.683445630516106
17,WP_MALE_INFERTILITY,66,Up,0.0171784392290959,0.683445630516106
18,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0175890594861076,0.683445630516106
19,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.0178286460920918,0.683445630516106
20,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0189582491738413,0.683445630516106
21,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0200247290221103,0.683445630516106
22,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.0208015568140982,0.683445630516106
23,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Up,0.0218712851382002,0.683445630516106
24,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0220115708554901,0.683445630516106
25,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0228764164911948,0.683445630516106
26,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.0233896694194096,0.683445630516106
27,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.0234438351908868,0.683445630516106
28,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0241204200785814,0.683445630516106
29,WP_MONOAMINE_GPCRS,3,Down,0.0248341317041768,0.683445630516106
30,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.0254669528476848,0.683445630516106
31,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Up,0.0269991765593463,0.683445630516106
32,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0272897593138099,0.683445630516106
33,WP_FERROPTOSIS,50,Up,0.0285223896176496,0.683445630516106
34,WP_NRF2_PATHWAY,67,Up,0.0288624650753247,0.683445630516106
35,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Up,0.0309092937104056,0.683445630516106
36,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.0347374936040859,0.683445630516106
37,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.034865372111178,0.683445630516106
38,WP_ZINC_HOMEOSTASIS,21,Up,0.034869524007104,0.683445630516106
39,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.0355304055916884,0.683445630516106
40,WP_PPARALPHA_PATHWAY,15,Up,0.0361162509576604,0.683445630516106
41,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Up,0.0379096119568248,0.683445630516106
42,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0382939714554039,0.683445630516106
43,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.0389848867890984,0.683445630516106
44,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0393704281466479,0.683445630516106
45,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.0397801904034939,0.683445630516106
46,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0403934941697697,0.683445630516106
47,WP_PPAR_SIGNALING,39,Up,0.0404506617611223,0.683445630516106
48,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0405324532960509,0.683445630516106
49,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.0407406762716414,0.683445630516106
50,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.0422146341497975,0.686458329552846
51,WP_MEVALONATE_PATHWAY,7,Down,0.0435165071756542,0.686458329552846
52,WP_CREATINE_PATHWAY,2,Down,0.0440619967048237,0.686458329552846
53,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.044348733150574,0.686458329552846
54,WP_PROTEASOME_DEGRADATION,57,Up,0.0457139883688151,0.686458329552846
55,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.0459309101282318,0.686458329552846
56,WP_CAMKK2_PATHWAY,29,Up,0.0467738093043177,0.686572700859806
57,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.0482263223436701,0.695474332745558
58,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0500014531587979,0.708641284422964
59,WP_ID_SIGNALING,12,Up,0.0511047679504224,0.712002021275376
60,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0530682551386813,0.727035095399934
61,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0548531206759163,0.739168281895134
62,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Up,0.0582166796522027,0.77184049474372
63,WP_TP53_NETWORK,16,Up,0.0598064061132529,0.780331203572919
64,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.062338029273446,0.794578086790521
65,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.0632728049206772,0.794578086790521
66,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0637982405452243,0.794578086790521
67,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Up,0.0692073140712867,0.849080778605935
68,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.0736033409037795,0.887687879928831
69,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.074637142597301,0.887687879928831
70,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.0755938583881,0.887687879928831
71,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.0774362554381815,0.896515520706833
72,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.080754085047582,0.903417706040699
73,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.0809782291461886,0.903417706040699
74,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.0815652188063132,0.903417706040699
75,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.0824286228139324,0.903417706040699
76,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.0850637455078296,0.920031563255736
77,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.0899491883340824,0.934755573848066
78,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.0907056481638636,0.934755573848066
79,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.0948644718404828,0.934755573848066
80,WP_TRANSLATION_FACTORS,49,Down,0.0955426155117025,0.934755573848066
81,WP_KLEEFSTRA_SYNDROME,24,Down,0.0976889525287772,0.934755573848066
82,WP_SPINAL_CORD_INJURY,63,Up,0.0978544684206216,0.934755573848066
83,WP_NEPHROGENESIS,4,Down,0.099570771343505,0.934755573848066
84,WP_SPINA_BIFIDA,10,Up,0.10309392754937,0.934755573848066
85,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Up,0.104181381908392,0.934755573848066
86,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.10419472001114,0.934755573848066
87,WP_FOXP3_IN_COVID19,9,Up,0.105953815747395,0.934755573848066
88,WP_FOLATE_METABOLISM,36,Up,0.106461442935836,0.934755573848066
89,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.1083429751023,0.934755573848066
90,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.109888859071099,0.934755573848066
91,WP_SMALL_LIGAND_GPCRS,7,Up,0.111080786523751,0.934755573848066
92,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.111357221489238,0.934755573848066
93,WP_ALLOGRAFT_REJECTION,48,Up,0.11318685721518,0.934755573848066
94,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.11574204229885,0.934755573848066
95,WP_DOPAMINE_METABOLISM,7,Up,0.116137817858949,0.934755573848066
96,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.116910306980389,0.934755573848066
97,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.118505036361322,0.934755573848066
98,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Down,0.121634242792308,0.934755573848066
99,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.122742882439611,0.934755573848066
100,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.124058551456611,0.934755573848066
101,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.125476148550292,0.934755573848066
102,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.126680537789285,0.934755573848066
103,WP_DRAVET_SYNDROME,12,Down,0.130047831759714,0.934755573848066
104,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.13011521742315,0.934755573848066
105,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.131149380280018,0.934755573848066
106,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.134656183744549,0.934755573848066
107,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.136607249581658,0.934755573848066
108,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.137329495944374,0.934755573848066
109,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.139478068707228,0.934755573848066
110,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.139894751789299,0.934755573848066
111,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.140433241285051,0.934755573848066
112,WP_PREIMPLANTATION_EMBRYO,20,Up,0.140676307844087,0.934755573848066
113,WP_SERINE_METABOLISM,5,Up,0.140749606572965,0.934755573848066
114,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Up,0.142768334122329,0.934755573848066
115,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.147864261764076,0.934755573848066
116,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.149233832429399,0.934755573848066
117,WP_HEME_BIOSYNTHESIS,8,Up,0.149233832429399,0.934755573848066
118,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.151536783437567,0.934755573848066
119,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.151888750058514,0.934755573848066
120,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Down,0.152000403859459,0.934755573848066
121,WP_RETINOL_METABOLISM,6,Down,0.154373192429512,0.934755573848066
122,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.155055901431002,0.934755573848066
123,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.15632764142444,0.934755573848066
124,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.156869935900763,0.934755573848066
125,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.157120268777819,0.934755573848066
126,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.157338041187947,0.934755573848066
127,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.158116397543638,0.934755573848066
128,WP_NUCLEOTIDE_GPCRS,5,Down,0.159282020038353,0.934755573848066
129,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.159903588656123,0.934755573848066
130,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.160300845831991,0.934755573848066
131,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.160363455789005,0.934755573848066
132,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.1614555096837,0.934755573848066
133,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.162811142376505,0.934755573848066
134,WP_AXON_GUIDANCE,35,Up,0.163310672114719,0.934755573848066
135,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.165600486781253,0.934755573848066
136,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.165844927169882,0.934755573848066
137,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.167702842118972,0.934755573848066
138,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.16824491796674,0.934755573848066
139,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.169160915605175,0.934755573848066
140,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.169294305855305,0.934755573848066
141,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.169983048929537,0.934755573848066
142,WP_IRINOTECAN_PATHWAY,5,Up,0.171009933043011,0.934755573848066
143,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.17159742297989,0.934755573848066
144,WP_IL7_SIGNALING,23,Up,0.174079893716949,0.934755573848066
145,WP_VITAMIN_B12_METABOLISM,23,Up,0.174311748199618,0.934755573848066
146,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.174554781876887,0.934755573848066
147,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.177028412026123,0.934755573848066
148,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.177541108660134,0.934755573848066
149,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.178896221166007,0.934755573848066
150,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.182931539838667,0.934755573848066
151,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.185377215051258,0.934755573848066
152,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.186517749331054,0.934755573848066
153,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.18798744516503,0.934755573848066
154,WP_ENERGY_METABOLISM,41,Down,0.188520033200268,0.934755573848066
155,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.188910079343069,0.934755573848066
156,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.189609738456399,0.934755573848066
157,WP_HUNGER_AND_SATIETY,2,Down,0.192404074978052,0.934755573848066
158,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Down,0.192422767717557,0.934755573848066
159,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.193695581939912,0.934755573848066
160,WP_CIRCADIAN_RHYTHM_GENES,114,Up,0.193767104434168,0.934755573848066
161,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Up,0.194767368739198,0.934755573848066
162,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.19575749361171,0.934755573848066
163,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.19582753398075,0.934755573848066
164,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.198457286708772,0.934755573848066
165,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Up,0.199158248265628,0.934755573848066
166,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.199413682564777,0.934755573848066
167,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.202101695239272,0.934755573848066
168,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.20262144343274,0.934755573848066
169,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Up,0.204493660861812,0.934755573848066
170,WP_IL18_SIGNALING,186,Up,0.205210368273411,0.934755573848066
171,WP_ADIPOGENESIS,84,Up,0.205830711468713,0.934755573848066
172,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.207684681617584,0.934755573848066
173,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.208348752403372,0.934755573848066
174,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.209362736828472,0.934755573848066
175,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.210064911193274,0.934755573848066
176,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.214012550972193,0.934755573848066
177,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Down,0.214396991574379,0.934755573848066
178,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.216173742533709,0.934755573848066
179,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.216864063034154,0.934755573848066
180,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Up,0.217353333985293,0.934755573848066
181,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.21740263206905,0.934755573848066
182,WP_EGFEGFR_SIGNALING,136,Up,0.221803038985047,0.934755573848066
183,WP_IL26_SIGNALING,31,Up,0.224251738895467,0.934755573848066
184,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.224381591301199,0.934755573848066
185,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.22480927556485,0.934755573848066
186,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.22497402958995,0.934755573848066
187,WP_BASE_EXCISION_REPAIR,29,Up,0.225015663158996,0.934755573848066
188,WP_RANKLRANK_SIGNALING,47,Up,0.22758274719382,0.934755573848066
189,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.231269175414474,0.934755573848066
190,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.231561093589991,0.934755573848066
191,WP_GPR40_PATHWAY,7,Up,0.231936923361224,0.934755573848066
192,WP_G13_SIGNALING,29,Down,0.232041016293587,0.934755573848066
193,WP_AEROBIC_GLYCOLYSIS,10,Up,0.232865966655859,0.934755573848066
194,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.232865966655859,0.934755573848066
195,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.23409491135556,0.934755573848066
196,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Up,0.234708813478206,0.934755573848066
197,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.235085930389439,0.934755573848066
198,WP_HEART_DEVELOPMENT,16,Up,0.237689752250212,0.934755573848066
199,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.239040054205756,0.934755573848066
200,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.239477069255767,0.934755573848066
201,WP_SEROTONIN_AND_ANXIETY,7,Down,0.239951253795679,0.934755573848066
202,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.240199174686566,0.934755573848066
203,WP_BENZENE_METABOLISM,3,Up,0.240945528562713,0.934755573848066
204,WP_JOUBERT_SYNDROME,71,Down,0.242878585571714,0.934755573848066
205,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.243694159950612,0.934755573848066
206,WP_IL17_SIGNALING,25,Up,0.245030808041918,0.934755573848066
207,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.246356857244771,0.934755573848066
208,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.247326093620192,0.934755573848066
209,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.249725525394259,0.934755573848066
210,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.253655854238625,0.934755573848066
211,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.25491922112405,0.934755573848066
212,WP_IL11_SIGNALING,40,Up,0.257144145642847,0.934755573848066
213,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.259374255976686,0.934755573848066
214,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.259456702436809,0.934755573848066
215,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Down,0.259621446977149,0.934755573848066
216,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.263242729601863,0.934755573848066
217,WP_RAS_SIGNALING,113,Up,0.268665879050816,0.934755573848066
218,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.268793354419757,0.934755573848066
219,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.269197668770206,0.934755573848066
220,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Down,0.26951431564974,0.934755573848066
221,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.271618103484219,0.934755573848066
222,WP_CORI_CYCLE,11,Up,0.27317674129173,0.934755573848066
223,WP_FOXA2_PATHWAY,9,Up,0.27432325885648,0.934755573848066
224,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.27618888542388,0.934755573848066
225,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.277019328849872,0.934755573848066
226,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.277267768064365,0.934755573848066
227,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.277267768064365,0.934755573848066
228,WP_PROLACTIN_SIGNALING,68,Up,0.277548817158612,0.934755573848066
229,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.278090090839421,0.934755573848066
230,WP_PROSTAGLANDIN_SIGNALING,20,Down,0.278817342223664,0.934755573848066
231,WP_MAPK_SIGNALING,156,Up,0.279963679849653,0.934755573848066
232,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.280434330227938,0.934755573848066
233,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.280619749568521,0.934755573848066
234,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.281888933120559,0.934755573848066
235,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.282128548435639,0.934755573848066
236,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.282178470833484,0.934755573848066
237,WP_NEPHROTIC_SYNDROME,27,Up,0.282306865045535,0.934755573848066
238,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.282306918137726,0.934755573848066
239,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.282660127162816,0.934755573848066
240,WP_VALPROIC_ACID_PATHWAY,8,Down,0.28529577534902,0.934755573848066
241,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.285992835552943,0.934755573848066
242,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.288558750067085,0.934755573848066
243,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.290169081756158,0.934755573848066
244,WP_TRYPTOPHAN_METABOLISM,18,Down,0.290681274848914,0.934755573848066
245,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.29135854891053,0.934755573848066
246,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.291743580452016,0.934755573848066
247,WP_P38_MAPK_SIGNALING,31,Down,0.291911226959653,0.934755573848066
248,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.292060594644503,0.934755573848066
249,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.29218515114312,0.934755573848066
250,WP_ATR_SIGNALING,10,Up,0.294361853297924,0.934755573848066
251,WP_COMPLEMENT_ACTIVATION,11,Up,0.294643172921057,0.934755573848066
252,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.295686801898612,0.934755573848066
253,WP_TAMOXIFEN_METABOLISM,2,Up,0.295733316047432,0.934755573848066
254,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.296955584135615,0.934755573848066
255,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.297163784484648,0.934755573848066
256,WP_DNA_DAMAGE_RESPONSE,57,Up,0.29823740624822,0.934755573848066
257,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.298673435446146,0.934755573848066
258,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Down,0.300116378543765,0.934755573848066
259,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.300703045528113,0.934755573848066
260,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.30129545482171,0.934755573848066
261,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.301303761360471,0.934755573848066
262,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Down,0.301736397279102,0.934755573848066
263,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.302657939228173,0.934755573848066
264,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.30407981933431,0.934755573848066
265,WP_CHOLESTASIS,9,Down,0.307095551294006,0.934755573848066
266,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.307489879438671,0.934755573848066
267,WP_TYPE_II_DIABETES_MELLITUS,13,Up,0.308168256666154,0.934755573848066
268,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.308390259184553,0.934755573848066
269,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.312754470050783,0.934755573848066
270,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.317428995503028,0.934755573848066
271,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.318166032640027,0.934755573848066
272,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.320173613880683,0.934755573848066
273,WP_SPHINGOLIPID_PATHWAY,19,Down,0.320203332002029,0.934755573848066
274,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.320461378728,0.934755573848066
275,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.320752211785332,0.934755573848066
276,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.320769760775766,0.934755573848066
277,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.322591223942541,0.934755573848066
278,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.323049613031064,0.934755573848066
279,WP_ASPIRIN_AND_MIRNAS,8,Down,0.324468112852226,0.934755573848066
280,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.325717369645187,0.934755573848066
281,WP_OSTEOCLAST_SIGNALING,8,Up,0.325761636924973,0.934755573848066
282,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.326560181623958,0.934755573848066
283,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.326930213991138,0.934755573848066
284,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.327294782181024,0.934755573848066
285,WP_GPCRS_OTHER,11,Up,0.328619557405268,0.934755573848066
286,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.329138853349168,0.934755573848066
287,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.329774089554035,0.934755573848066
288,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Up,0.33028211331627,0.934755573848066
289,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.333665799205434,0.934755573848066
290,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.334670837743495,0.934755573848066
291,WP_NEURAL_CREST_DIFFERENTIATION,37,Up,0.335138852524821,0.934755573848066
292,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Down,0.335959528468896,0.934755573848066
293,WP_NEOVASCULARIZATION_PROCESSES,20,Up,0.336939808776108,0.934755573848066
294,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.337261261992384,0.934755573848066
295,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.338218443904668,0.934755573848066
296,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Up,0.339230087035036,0.934755573848066
297,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.344114995075085,0.934755573848066
298,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.344440984307815,0.934755573848066
299,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.346546953180206,0.934755573848066
300,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.34670755712152,0.934755573848066
301,WP_ERBB_SIGNALING,67,Up,0.347901449998872,0.934755573848066
302,WP_OVARIAN_INFERTILITY,20,Down,0.348789298007241,0.934755573848066
303,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.349443081751056,0.934755573848066
304,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Up,0.350118257910188,0.934755573848066
305,WP_IL4_SIGNALING,50,Down,0.35439530750139,0.934755573848066
306,WP_SILDENAFIL_TREATMENT,10,Up,0.355022806986662,0.934755573848066
307,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.355847422765507,0.934755573848066
308,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.357297124731093,0.934755573848066
309,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.357780794343933,0.934755573848066
310,WP_SLEEP_REGULATION,10,Up,0.358522567846426,0.934755573848066
311,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.361465776581909,0.934755573848066
312,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.361663233448803,0.934755573848066
313,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.362005645376274,0.934755573848066
314,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.362450240099233,0.934755573848066
315,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.364120715549536,0.934755573848066
316,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.364123986145734,0.934755573848066
317,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.364555340728214,0.934755573848066
318,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.367949967450109,0.934755573848066
319,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.36806593134279,0.934755573848066
320,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.368348954867225,0.934755573848066
321,WP_CILIOPATHIES,125,Down,0.368496886390626,0.934755573848066
322,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.368898502302542,0.934755573848066
323,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.370596158086428,0.934755573848066
324,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.370791351658627,0.934755573848066
325,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.370816960953051,0.934755573848066
326,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.370925235272554,0.934755573848066
327,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.372148102369217,0.934755573848066
328,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.372992491754459,0.934755573848066
329,WP_IL1_SIGNALING,51,Down,0.379462198232241,0.936910528163717
330,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.381698249467603,0.936910528163717
331,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.382576931107643,0.936910528163717
332,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.383172596889536,0.936910528163717
333,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.38346205578552,0.936910528163717
334,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.383520042715338,0.936910528163717
335,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Down,0.384120121456155,0.936910528163717
336,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.384307667534323,0.936910528163717
337,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.385610449581384,0.936910528163717
338,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.385618198804105,0.936910528163717
339,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.387655292188719,0.936910528163717
340,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Up,0.38993235930765,0.936910528163717
341,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.390442406736656,0.936910528163717
342,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.391938852025241,0.936910528163717
343,WP_OREXIN_RECEPTOR_PATHWAY,117,Up,0.394475792579848,0.936910528163717
344,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.394892762265805,0.936910528163717
345,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.395763175544476,0.936910528163717
346,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.396424043674832,0.936910528163717
347,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.398183631180082,0.936910528163717
348,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.400493131975857,0.936910528163717
349,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.401432077123811,0.936910528163717
350,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.402875730799123,0.936910528163717
351,WP_NAD_METABOLISM,11,Down,0.403602556801569,0.936910528163717
352,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.404560679669372,0.936910528163717
353,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Up,0.408474606171998,0.936910528163717
354,WP_CHOLESTEROL_METABOLISM,52,Down,0.409369199979831,0.936910528163717
355,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.410033671623247,0.936910528163717
356,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.411395927847132,0.936910528163717
357,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.411492770004166,0.936910528163717
358,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Up,0.411659827630949,0.936910528163717
359,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.41544831949983,0.936910528163717
360,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.416768913571075,0.936910528163717
361,WP_ANGIOGENESIS,12,Up,0.419142428120036,0.936910528163717
362,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.420014164912991,0.936910528163717
363,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.420026447314575,0.936910528163717
364,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.420475865872972,0.936910528163717
365,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.420565311580516,0.936910528163717
366,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.420731327328181,0.936910528163717
367,WP_NUCLEAR_RECEPTORS,20,Up,0.421741755783806,0.936910528163717
368,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.42269552086313,0.936910528163717
369,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.422852668327524,0.936910528163717
370,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.42351945581291,0.936910528163717
371,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.423755561028333,0.936910528163717
372,WP_CANCER_PATHWAYS,295,Up,0.424183063063677,0.936910528163717
373,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.425936360047634,0.936910528163717
374,WP_WNT_SIGNALING_WP428,58,Down,0.426826146486694,0.936910528163717
375,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.428950036467523,0.936910528163717
376,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.430312369672511,0.936910528163717
377,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.430656159651936,0.936910528163717
378,WP_INSULIN_SIGNALING,129,Up,0.430842067695724,0.936910528163717
379,WP_PRION_DISEASE_PATHWAY,28,Down,0.437266983644514,0.943853153597928
380,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.438042775671064,0.943853153597928
381,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.43894542102449,0.943853153597928
382,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.440305514789649,0.943853153597928
383,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.443054036178574,0.943853153597928
384,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.443737765199552,0.943853153597928
385,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Down,0.445638734252518,0.943853153597928
386,WP_LUNG_FIBROSIS,30,Down,0.446434273024123,0.943853153597928
387,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.446589525438286,0.943853153597928
388,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.447718091165474,0.943853153597928
389,WP_BLADDER_CANCER,28,Up,0.448422848049039,0.943853153597928
390,WP_BARDETBIEDL_SYNDROME,65,Down,0.448725780833729,0.943853153597928
391,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.44896177987444,0.943853153597928
392,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Up,0.452947527260896,0.946322810882652
393,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.453257146187467,0.946322810882652
394,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.453590252418206,0.946322810882652
395,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.454813702954816,0.946473072984452
396,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.456829248970444,0.948266774378042
397,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.460320929977402,0.950987897154488
398,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.460968999047171,0.950987897154488
399,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.462866474650702,0.950987897154488
400,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.464742623410267,0.950987897154488
401,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.470485768855182,0.950987897154488
402,WP_MELANOMA,52,Up,0.471634113450961,0.950987897154488
403,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.474493155179145,0.950987897154488
404,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.477175339497275,0.950987897154488
405,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.477298604938701,0.950987897154488
406,WP_COPPER_HOMEOSTASIS,39,Up,0.478290184445841,0.950987897154488
407,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.478319639980971,0.950987897154488
408,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.479135548178032,0.950987897154488
409,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Up,0.479673389210501,0.950987897154488
410,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.47981610955506,0.950987897154488
411,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.481973282321759,0.950987897154488
412,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Up,0.483311200139323,0.950987897154488
413,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,61,Down,0.483640279760798,0.950987897154488
414,WP_CHEMOKINE_SIGNALING,107,Up,0.484219996645381,0.950987897154488
415,WP_IL9_SIGNALING,15,Up,0.484915853722457,0.950987897154488
416,WP_THERMOGENESIS,72,Down,0.484968840792177,0.950987897154488
417,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.486129338062371,0.950987897154488
418,WP_SMALL_CELL_LUNG_CANCER,67,Up,0.487150690692633,0.950987897154488
419,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.489872973421528,0.950987897154488
420,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.490177628924649,0.950987897154488
421,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.492685030044942,0.950987897154488
422,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.492910565975966,0.950987897154488
423,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.493594446999831,0.950987897154488
424,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.495775662410783,0.950987897154488
425,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.496255406487225,0.950987897154488
426,WP_G_PROTEIN_SIGNALING,61,Up,0.496817693767892,0.950987897154488
427,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.497340491379765,0.950987897154488
428,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.498004561407107,0.950987897154488
429,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.498097828545218,0.950987897154488
430,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.499128745474441,0.950987897154488
431,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.501534420324085,0.950987897154488
432,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.502198658264272,0.950987897154488
433,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.502647308645825,0.950987897154488
434,WP_TRANSSULFURATION_PATHWAY,8,Down,0.503198851606197,0.950987897154488
435,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.503260018567156,0.950987897154488
436,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.506902446372197,0.954752842654932
437,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.507575416350615,0.954752842654932
438,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Down,0.513238952314815,0.958513155856787
439,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.513830761108352,0.958513155856787
440,WP_RETT_SYNDROME,31,Down,0.514024409748681,0.958513155856787
441,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.51423880989397,0.958513155856787
442,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.515443829991893,0.958585584283567
443,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.517046053969715,0.959394709623264
444,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Up,0.521580738787781,0.963578536678376
445,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Up,0.521645314868464,0.963578536678376
446,WP_CCL18_SIGNALING,20,Up,0.524195282605023,0.965735371104132
447,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.525162665308451,0.965735371104132
448,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.529969695016599,0.967167968935598
449,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.530661763386046,0.967167968935598
450,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.531467167936313,0.967167968935598
451,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.533651645263281,0.967167968935598
452,WP_MONOAMINE_TRANSPORT,11,Up,0.533796622074243,0.967167968935598
453,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.535301568974151,0.967167968935598
454,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.537205345191288,0.967167968935598
455,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.539373971070683,0.967167968935598
456,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.539454658597888,0.967167968935598
457,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.542221544133952,0.967167968935598
458,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.542560458749261,0.967167968935598
459,WP_FRAGILE_X_SYNDROME,83,Down,0.545182334853393,0.967167968935598
460,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.546663323284266,0.967167968935598
461,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.548419343742961,0.967167968935598
462,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.548671831247591,0.967167968935598
463,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.548900554725947,0.967167968935598
464,WP_OSTEOBLAST_SIGNALING,2,Up,0.549308455948307,0.967167968935598
465,WP_METHYLATION_PATHWAYS,5,Up,0.551764913189759,0.967167968935598
466,WP_GASTRIN_SIGNALING,92,Up,0.551926656220135,0.967167968935598
467,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.5526938769155,0.967167968935598
468,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.5526938769155,0.967167968935598
469,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.553060261656361,0.967167968935598
470,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.554084585664196,0.967167968935598
471,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.554965585992181,0.967167968935598
472,WP_HIPPOYAP_SIGNALING,16,Up,0.555356789948421,0.967167968935598
473,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.556826822652792,0.967677903214788
474,WP_TNFALPHA_SIGNALING,82,Down,0.562573097051424,0.970337366502585
475,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.563306626641467,0.970337366502585
476,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.563663690935074,0.970337366502585
477,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Up,0.56404526391773,0.970337366502585
478,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.566305525950697,0.970337366502585
479,WP_VITAMIN_B12_DISORDERS,9,Down,0.56649430012847,0.970337366502585
480,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.567761289312962,0.970337366502585
481,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.567800819084846,0.970337366502585
482,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.5732463832154,0.974415837238203
483,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.57382385004451,0.974415837238203
484,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.574510790363059,0.974415837238203
485,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.578094627834242,0.974415837238203
486,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.578939117256094,0.974415837238203
487,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.579318779943452,0.974415837238203
488,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.580584701880589,0.974415837238203
489,WP_OPIOID_RECEPTOR_PATHWAYS,24,Up,0.581665323753233,0.974415837238203
490,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Down,0.585565617846168,0.974415837238203
491,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.585898568585089,0.974415837238203
492,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.588056925002806,0.974415837238203
493,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.589079116132907,0.974415837238203
494,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.590030413545531,0.974415837238203
495,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.590543475968549,0.974415837238203
496,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.590743699204859,0.974415837238203
497,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.591803919440534,0.974415837238203
498,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.59191320665125,0.974415837238203
499,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.59259606500538,0.974415837238203
500,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.592710363283578,0.974415837238203
501,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.594033922767283,0.97464248406129
502,WP_PEPTIDE_GPCRS,13,Up,0.597968172364898,0.979143102956068
503,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.601434012906975,0.982452992559836
504,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.603522892139287,0.982452992559836
505,WP_ONCOSTATIN_M_SIGNALING,55,Up,0.604898306636402,0.982452992559836
506,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Up,0.606672328556914,0.982452992559836
507,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.607257115092988,0.982452992559836
508,WP_BDNFTRKB_SIGNALING,26,Up,0.610152753713984,0.982452992559836
509,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.610159699469324,0.982452992559836
510,WP_ARYLAMINE_METABOLISM,1,Up,0.61083330843798,0.982452992559836
511,WP_TCELL_RECEPTOR_SIGNALING,71,Up,0.612811384975469,0.982452992559836
512,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.613270350451288,0.982452992559836
513,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.614475980482697,0.982452992559836
514,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.616242511983903,0.982452992559836
515,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.619747835018672,0.982452992559836
516,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.619780914312978,0.982452992559836
517,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.620281072373062,0.982452992559836
518,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.621278502044618,0.982452992559836
519,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Up,0.621340998295517,0.982452992559836
520,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.621503109648558,0.982452992559836
521,WP_MEASLES_VIRUS_INFECTION,98,Down,0.623441386478159,0.983625373675714
522,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.628319085563664,0.98389805409502
523,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.630354166344397,0.98389805409502
524,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.630400273508184,0.98389805409502
525,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.631012029057197,0.98389805409502
526,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.631291727458854,0.98389805409502
527,WP_IL6_SIGNALING,38,Up,0.632014639333058,0.98389805409502
528,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.633834450856987,0.98389805409502
529,WP_LEPTIN_SIGNALING,69,Down,0.634672173544598,0.98389805409502
530,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.635454968289293,0.98389805409502
531,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.63558377947014,0.98389805409502
532,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.637951276627065,0.984829276440443
533,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Up,0.640782740257134,0.984829276440443
534,WP_ECTODERM_DIFFERENTIATION,74,Down,0.641555478788231,0.984829276440443
535,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.64206479023809,0.984829276440443
536,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.642175781231238,0.984829276440443
537,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.646761462925492,0.98579129899031
538,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.651213794006148,0.98579129899031
539,WP_VEGFAVEGFR2_SIGNALING,333,Up,0.652049201282946,0.98579129899031
540,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.653597544116508,0.98579129899031
541,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.653703679001279,0.98579129899031
542,WP_AGERAGE_PATHWAY,54,Up,0.653824397325374,0.98579129899031
543,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.65939450029051,0.98579129899031
544,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.661032746743224,0.98579129899031
545,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.666009949696097,0.98579129899031
546,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.666573829485214,0.98579129899031
547,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.667027287342412,0.98579129899031
548,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.667110713547903,0.98579129899031
549,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.667940542604372,0.98579129899031
550,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.667986282750586,0.98579129899031
551,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.668151623071934,0.98579129899031
552,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.66937348706704,0.98579129899031
553,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.671044186703669,0.98579129899031
554,WP_ENDOTHELIN_PATHWAYS,11,Down,0.671079093056952,0.98579129899031
555,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.671318787123369,0.98579129899031
556,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.674706244736657,0.98579129899031
557,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.674946260627191,0.98579129899031
558,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.676559704129442,0.98579129899031
559,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.678275608222543,0.98579129899031
560,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.679204812180557,0.98579129899031
561,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.680232862521884,0.98579129899031
562,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.681073871752551,0.98579129899031
563,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.682106323446632,0.98579129899031
564,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.68268353742675,0.98579129899031
565,WP_TGFB_SMAD_SIGNALING,7,Down,0.683959353416185,0.98579129899031
566,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.686296549720667,0.98579129899031
567,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.686459570034868,0.98579129899031
568,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.686978811628379,0.98579129899031
569,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.691842920026801,0.98579129899031
570,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Up,0.692046421969637,0.98579129899031
571,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.692873732133461,0.98579129899031
572,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.694149052278222,0.98579129899031
573,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.694227864467651,0.98579129899031
574,WP_MIRNA_BIOGENESIS,6,Up,0.694851738415898,0.98579129899031
575,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.69750458243767,0.98579129899031
576,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.698542872910012,0.98579129899031
577,WP_ESTROGEN_SIGNALING,21,Down,0.699802257547014,0.98579129899031
578,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.699819914100973,0.98579129899031
579,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.700700834729219,0.98579129899031
580,WP_VITAMIN_D_METABOLISM,6,Down,0.702734269137796,0.98579129899031
581,WP_EICOSANOID_SYNTHESIS,13,Down,0.706688561796112,0.98579129899031
582,WP_ENDODERM_DIFFERENTIATION,80,Down,0.70714167385477,0.98579129899031
583,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.707362892108593,0.98579129899031
584,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.708543925691397,0.98579129899031
585,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.712215755532028,0.98579129899031
586,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.71268796854405,0.98579129899031
587,WP_KININKALLIKREIN_PATHWAY,2,Up,0.71538364432157,0.98579129899031
588,WP_NGLYCAN_BIOSYNTHESIS,51,Up,0.716598963267571,0.98579129899031
589,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.718869174348788,0.98579129899031
590,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.719241980014043,0.98579129899031
591,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.720160018786351,0.98579129899031
592,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.720604073211747,0.98579129899031
593,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.721234828731839,0.98579129899031
594,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.722655896128341,0.98579129899031
595,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.723792820554924,0.98579129899031
596,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.724232568426919,0.98579129899031
597,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.726176708789759,0.98579129899031
598,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.72789695504465,0.98579129899031
599,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Down,0.731401539237232,0.98579129899031
600,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.733580511404757,0.98579129899031
601,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.734053754507487,0.98579129899031
602,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.734975535992684,0.98579129899031
603,WP_MAPK_CASCADE,30,Down,0.736679622237056,0.98579129899031
604,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.739551990413207,0.98579129899031
605,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.741732400102661,0.98579129899031
606,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.743087666204846,0.98579129899031
607,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.743690691903906,0.98579129899031
608,WP_CELL_CYCLE,90,Up,0.745534584116237,0.98579129899031
609,WP_PDGF_PATHWAY,35,Up,0.74586786098007,0.98579129899031
610,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.74665724256833,0.98579129899031
611,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.746898982774804,0.98579129899031
612,WP_IL3_SIGNALING,46,Down,0.747147341241778,0.98579129899031
613,WP_KIT_RECEPTOR_SIGNALING,50,Up,0.747512948454346,0.98579129899031
614,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.749315493020917,0.98579129899031
615,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.749776988482476,0.98579129899031
616,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.750715848778559,0.98579129899031
617,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.753041346934936,0.98579129899031
618,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.755854101999222,0.98579129899031
619,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.756701470389324,0.98579129899031
620,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.756830809465599,0.98579129899031
621,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.758186532914726,0.98579129899031
622,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.75876654566943,0.98579129899031
623,WP_BREAST_CANCER_PATHWAY,84,Down,0.761792773973857,0.98579129899031
624,WP_PURINERGIC_SIGNALING,14,Up,0.762344240782799,0.98579129899031
625,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.765436836478183,0.98579129899031
626,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.76682241258991,0.98579129899031
627,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.766888642267237,0.98579129899031
628,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Up,0.7670566108394,0.98579129899031
629,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Up,0.769164379333975,0.98579129899031
630,WP_PYRIMIDINE_METABOLISM,71,Up,0.769329100892693,0.98579129899031
631,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.769711504448389,0.98579129899031
632,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.770554057965762,0.98579129899031
633,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Up,0.773329072813497,0.98579129899031
634,WP_NEUROINFLAMMATION,10,Down,0.773906213293702,0.98579129899031
635,WP_AUTOPHAGY,27,Down,0.775213266290649,0.98579129899031
636,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.77562162078984,0.98579129899031
637,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.776075403590218,0.98579129899031
638,WP_NOTCH_SIGNALING_WP61,48,Up,0.77620989921845,0.98579129899031
639,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.776677981057331,0.98579129899031
640,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.777735350976832,0.98579129899031
641,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.780568460438467,0.98579129899031
642,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.782234465723554,0.98579129899031
643,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.782304844198297,0.98579129899031
644,WP_WNT_SIGNALING_WP363,37,Down,0.783445266093968,0.98579129899031
645,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.786577956934388,0.98579129899031
646,WP_GLUCURONIDATION,7,Up,0.78735799758446,0.98579129899031
647,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.789025778118934,0.98579129899031
648,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.789818860111738,0.98579129899031
649,WP_ALSTROM_SYNDROME,27,Down,0.790859706616503,0.98579129899031
650,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Up,0.791566235509461,0.98579129899031
651,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.791728971398583,0.98579129899031
652,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.795032119065454,0.98579129899031
653,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.796385066312068,0.98579129899031
654,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.796766379204122,0.98579129899031
655,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.797780965096185,0.98579129899031
656,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.799122019191966,0.98579129899031
657,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Down,0.802065894111254,0.98579129899031
658,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Down,0.80403151882776,0.98579129899031
659,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.804336659759072,0.98579129899031
660,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.805285190188934,0.98579129899031
661,WP_PDGFRBETA_PATHWAY,27,Up,0.805562905836023,0.98579129899031
662,WP_ALZHEIMERS_DISEASE,182,Up,0.806355370520934,0.98579129899031
663,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Up,0.806355370520934,0.98579129899031
664,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.806969956671328,0.98579129899031
665,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Up,0.807681354889887,0.98579129899031
666,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.808110712435473,0.98579129899031
667,WP_DNA_MISMATCH_REPAIR,21,Down,0.808474113590548,0.98579129899031
668,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.80892274217951,0.98579129899031
669,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.809101899820555,0.98579129899031
670,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.809524618840827,0.98579129899031
671,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.810539721893468,0.98579129899031
672,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.814131820178883,0.98579129899031
673,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.814236582333261,0.98579129899031
674,WP_TAR_SYNDROME,43,Down,0.815419673226422,0.98579129899031
675,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.815793703310243,0.98579129899031
676,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.816328447882948,0.98579129899031
677,WP_IL19_SIGNALING,20,Up,0.816376644931466,0.98579129899031
678,WP_MRNA_PROCESSING,124,Down,0.817073669567683,0.98579129899031
679,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Up,0.818368254547628,0.98579129899031
680,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.819578072367497,0.98579129899031
681,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.820610234823832,0.98579129899031
682,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.822456763839617,0.98579129899031
683,WP_COMPLEMENT_SYSTEM,47,Up,0.824021691828338,0.98579129899031
684,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.824087217174594,0.98579129899031
685,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.824087217174594,0.98579129899031
686,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.824615984938012,0.98579129899031
687,WP_ENDOMETRIAL_CANCER,49,Up,0.82632869699238,0.98579129899031
688,WP_GLUTATHIONE_METABOLISM,10,Up,0.826424533853132,0.98579129899031
689,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.82815975622062,0.98579129899031
690,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.82815975622062,0.98579129899031
691,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.830775945052629,0.98579129899031
692,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.832076181958627,0.98579129899031
693,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.832234509341462,0.98579129899031
694,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.832989502349592,0.98579129899031
695,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.836897786229678,0.98579129899031
696,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.839298115857487,0.98579129899031
697,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.839806824491719,0.98579129899031
698,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.840563289556367,0.98579129899031
699,WP_NRF2ARE_REGULATION,20,Up,0.840659423025957,0.98579129899031
700,WP_IL2_SIGNALING,37,Up,0.843078910933897,0.98579129899031
701,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.843895382149808,0.98579129899031
702,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.845477375080725,0.98579129899031
703,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.845486139749209,0.98579129899031
704,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.849766923958874,0.98579129899031
705,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Up,0.849906281529339,0.98579129899031
706,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Up,0.850032674933263,0.98579129899031
707,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.85014296386553,0.98579129899031
708,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.850274976866338,0.98579129899031
709,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.850274976866338,0.98579129899031
710,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.854105352815875,0.988837464809366
711,WP_CYTOSINE_METHYLATION,7,Down,0.855518123881664,0.98908002507838
712,WP_MTHFR_DEFICIENCY,18,Down,0.857484681251776,0.989961247175506
713,WP_NRXN1_DELETION_SYNDROME,2,Down,0.860874718734359,0.991268058946695
714,WP_CILIARY_LANDSCAPE,183,Down,0.861334855014767,0.991268058946695
715,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.862234382173828,0.991268058946695
716,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.863646327923335,0.991504583174555
717,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.866754638969576,0.991845652704991
718,WP_PI3KAKT_SIGNALING,173,Up,0.86822689604161,0.991845652704991
719,WP_HISTONE_MODIFICATIONS,36,Up,0.868806481908194,0.991845652704991
720,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.868924332895371,0.991845652704991
721,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.871035582657508,0.991845652704991
722,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.871183164541367,0.991845652704991
723,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.874935513116076,0.992502119757042
724,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.875510447453589,0.992502119757042
725,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.875534815365038,0.992502119757042
726,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.876589463435051,0.992502119757042
727,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.880883407645232,0.995923096424166
728,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.882783752279659,0.995923096424166
729,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.885504622503523,0.995923096424166
730,WP_KALLMANN_SYNDROME,11,Down,0.885729166230259,0.995923096424166
731,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.886109912156874,0.995923096424166
732,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.888939301929954,0.995923096424166
733,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.889319153022699,0.995923096424166
734,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Down,0.890550923747537,0.995923096424166
735,WP_PURINE_METABOLISM,9,Down,0.891909176277934,0.995923096424166
736,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.893224838953101,0.995923096424166
737,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.894812966093736,0.995923096424166
738,WP_APOPTOSIS,70,Down,0.894999784522594,0.995923096424166
739,WP_GLYOXYLATE_METABOLISM,5,Down,0.895361518561386,0.995923096424166
740,WP_NOTCH_SIGNALING_WP268,34,Down,0.898085056622655,0.996277246238165
741,WP_PLEURAL_MESOTHELIOMA,245,Down,0.898344554110369,0.996277246238165
742,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.902175009144933,0.996277246238165
743,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.904538798567496,0.996277246238165
744,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.905223892989705,0.996277246238165
745,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Up,0.905865930505689,0.996277246238165
746,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.906026331875253,0.996277246238165
747,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.910079561192268,0.996277246238165
748,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.911014155838327,0.996277246238165
749,WP_IL5_SIGNALING,37,Up,0.913883363575451,0.996277246238165
750,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.914298259178824,0.996277246238165
751,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.916371636944693,0.996277246238165
752,WP_DNA_REPLICATION,35,Up,0.918453092390259,0.996277246238165
753,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.919153795945552,0.996277246238165
754,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.91953135887725,0.996277246238165
755,WP_STEROID_BIOSYNTHESIS,2,Up,0.919813142810915,0.996277246238165
756,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.91991028392,0.996277246238165
757,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.920836652858075,0.996277246238165
758,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.921765187763826,0.996277246238165
759,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.921834686076417,0.996277246238165
760,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.923088773756941,0.996277246238165
761,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.924840655628066,0.996277246238165
762,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.927793339492486,0.996277246238165
763,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.931279535566357,0.996277246238165
764,WP_HYPERTROPHY_MODEL,12,Down,0.932451121150389,0.996277246238165
765,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.933830801862593,0.996277246238165
766,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.933890084965475,0.996277246238165
767,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.934134252353837,0.996277246238165
768,WP_CELLULAR_PROTEOSTASIS,6,Down,0.934173453219391,0.996277246238165
769,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.938044778302078,0.996277246238165
770,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.938610573709663,0.996277246238165
771,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.938943286432443,0.996277246238165
772,WP_HEPATITIS_B_INFECTION,116,Up,0.939594884742929,0.996277246238165
773,WP_BURN_WOUND_HEALING,59,Down,0.940115303930144,0.996277246238165
774,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.942222196120119,0.996277246238165
775,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.942351347476046,0.996277246238165
776,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.942426537196759,0.996277246238165
777,WP_GLIOBLASTOMA_SIGNALING,66,Up,0.943571752740143,0.996277246238165
778,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.944429077564781,0.996277246238165
779,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.944983286878425,0.996277246238165
780,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.946057925389812,0.996277246238165
781,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.946584585537721,0.996277246238165
782,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Up,0.952664297123405,0.998015738688831
783,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.953147028414678,0.998015738688831
784,WP_OSTEOPONTIN_SIGNALING,11,Down,0.954430452862266,0.998015738688831
785,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.959458332614365,0.998015738688831
786,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.96025795370983,0.998015738688831
787,WP_MACROPHAGE_MARKERS,8,Up,0.960747051277005,0.998015738688831
788,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.961695273174895,0.998015738688831
789,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.962119059088876,0.998015738688831
790,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.962346607131583,0.998015738688831
791,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.962974573265076,0.998015738688831
792,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.963172096380231,0.998015738688831
793,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.96557524190057,0.998015738688831
794,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.969437754807943,0.998015738688831
795,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.970825000975227,0.998015738688831
796,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.971527882634837,0.998015738688831
797,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.972244371213027,0.998015738688831
798,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.972250309839954,0.998015738688831
799,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.974153135601989,0.998015738688831
800,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.975208018432459,0.998015738688831
801,WP_FOCAL_ADHESION,114,Up,0.976019401245951,0.998015738688831
802,WP_B_CELL_RECEPTOR_SIGNALING,84,Down,0.976461207175939,0.998015738688831
803,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Down,0.977616304910077,0.998015738688831
804,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.978055750927686,0.998015738688831
805,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.978123459086486,0.998015738688831
806,WP_AMINO_ACID_METABOLISM,58,Down,0.979060392590631,0.998015738688831
807,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.981214731618698,0.998015738688831
808,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.981240597415113,0.998015738688831
809,WP_NPHP1_DELETION_SYNDROME,10,Up,0.982278230535294,0.998015738688831
810,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.983446165861257,0.998015738688831
811,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.986708105749709,0.998220325062682
812,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.989293519267488,0.998220325062682
813,WP_ATM_SIGNALING,34,Down,0.991096858037253,0.998220325062682
814,WP_NETRINUNC5B_SIGNALING,35,Down,0.991237177043358,0.998220325062682
815,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.991510501416162,0.998220325062682
816,WP_MATRIX_METALLOPROTEINASES,8,Up,0.991737281746868,0.998220325062682
817,WP_KREBS_CYCLE_DISORDERS,11,Up,0.992294847013917,0.998220325062682
818,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.993771906666418,0.998220325062682
819,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.994577185190191,0.998220325062682
820,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.998032592518741,0.99985720402973
821,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.999250929030465,0.99985720402973
822,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.99985720402973,0.99985720402973
